Overview

• QCi entered agreements to sell approximately 37.18 million shares in a market‑priced private placement, with closing expected on or about Oct. 8.
• The securities are unregistered under the Securities Act, and the company agreed to file an SEC resale registration to enable secondary sales.
• Proceeds are earmarked to accelerate commercialization, build volume production, expand sales and engineering teams, pursue strategic acquisitions, and support working capital.
• The raise lifts total capital secured since November 2024 to $1.64 billion, and QCi projects pro‑forma cash of roughly $1.5 billion and runway through 2028.
• Shares fell sharply on the announcement—reports cited intraday declines of roughly 9% to 14% and a 10% close lower—as analysts weighed dilution and minimal current revenue against some bullish long‑term targets.